Common Contracts
2 similar Royalty Repurchase Agreement contracts by Titan Pharmaceuticals Inc
EX-10.3 4 d257386dex103.htm AMENDED AND RESTATED ROYALTY REPURCHASE AGREEMENT AMENDED AND RESTATED ROYALTY REPURCHASE AGREEMENTRoyalty Repurchase Agreement • May 5th, 2020 • New York
This Amended and Restated Royalty Repurchase Agreement (this “Agreement”), dated November 14, 2011, is made by and between Deerfield Private Design Fund II, L.P., a Delaware limited partnership (“Design Fund II”), Deerfield Special Situations Fund, L.P., a Delaware limited partnership (“DSS”), Horizon Santé TTNP SARL, a Luxembourg limited company (“Horizon” and together with Design Fund II and DSS, “Deerfield”) and Titan Pharmaceuticals, Inc., a Delaware corporation (“Titan”).
AMENDED AND RESTATED ROYALTY REPURCHASE AGREEMENTRoyalty Repurchase Agreement • November 17th, 2011 • Titan Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
This Amended and Restated Royalty Repurchase Agreement (this “Agreement”), dated November 14, 2011, is made by and between Deerfield Private Design Fund II, L.P., a Delaware limited partnership (“Design Fund II”), Deerfield Special Situations Fund, L.P., a Delaware limited partnership (“DSS”), Horizon Santé TTNP SARL, a Luxembourg limited company (“Horizon” and together with Design Fund II and DSS, “Deerfield”) and Titan Pharmaceuticals, Inc., a Delaware corporation (“Titan”).
